Biomarkers for Inborn Errors of Metabolism
- Conditions
- Health Condition 1: E70-E88- Metabolic disorders
- Registration Number
- CTRI/2021/02/031462
- Lead Sponsor
- Centogene AG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Informed consent is obtained from the participant or from their parent/legal guardian, before any study related procedures
2. The participant aged between 2 months old and 40 years old
3. The diagnosis of an Inborn Error of Metabolism is genetically confirmed
1. Inability to provide informed consent
2. The participant is younger than 2 months old or older than 40 years old
3. The diagnosis of an Inborn Error of Metabolism (IEM) is not genetically confirmed
4. Previously enrolled in the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To identify or monitor Inborn Error of Metabolism disease biomarkersTimepoint: 2 years and above
- Secondary Outcome Measures
Name Time Method To explore the clinical robustness, specificity, and long-term variability of Inborn Error of Metabolism disease biomarkersTimepoint: 2 years and above